Rosario Distefano

758 citations
27 papers · 424 indexed · h-index 12
Topics
MicroRNA in disease regulation (11 papers)RNA modifications and cancer (9 papers)RNA regulation and disease (7 papers)

In The Last Decade

Rosario Distefano

26 papers receiving 419 citations

Peers

Rosario Distefano
Comparison fields: 5 of 69
  • Molecular Biology 330
  • Cancer Research 240
  • Genetics 44
  • Oncology 27
  • Immunology 20
Replace Tasneem Khanam with:
Tasneem Khanam Germany
Valentina Casà Italy
Ashley Cass United States
Rigu Gupta United States
Amirreza Bitaraf Iran
Xintao Wei United States
Wai-Kin Chan United States
Gilad Fuchs Israel
Eva Michalová Czechia
Rosario Distefano relative to Tasneem Khanam Germany Tasneem Khanam's profile →
Citations per field
00.5×8.4×
Tasneem Khanam · 1×
Citations per year

Countries citing papers authored by Rosario Distefano

Since Specialization
Citations

This map shows the geographic impact of Rosario Distefano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosario Distefano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosario Distefano more than expected).

Fields of papers citing papers by Rosario Distefano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosario Distefano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosario Distefano. The network helps show where Rosario Distefano may publish in the future.

Co-authorship network of co-authors of Rosario Distefano

This figure shows the co-authorship network connecting the top 25 collaborators of Rosario Distefano. A scholar is included among the top collaborators of Rosario Distefano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosario Distefano. Rosario Distefano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 2
3 6
4 1
5 7
6 7
7 29
8 67
9 9
10 22
11 26
12 26
13 24
14 23
15 33
16 36
17 10
18 22
19 1
20 9

About Rosario Distefano

Rosario Distefano is a scholar working on Cancer Research, Molecular Biology and Biophysics, having authored 27 papers that have together received 424 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (11 papers), RNA modifications and cancer (9 papers) and RNA regulation and disease (7 papers). The work is most often cited by research in Cancer Research (240 citations), Molecular Biology (330 citations) and Genetics (44 citations). Rosario Distefano has collaborated with scholars based in United States, Italy and Australia. Frequent co-authors include Giovanni Nigita, Carlo M. Croce, Luisa Tomasello, Mario Acunzo, Dario Veneziano, Gioacchino P. Marceca, Alfredo Ferro, Giulia Romano, Pierluigi Gasparini and Alfredo Pulvirenti. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cancer Research and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026